
The Promise and Challenges of CGRP as a Migraine Biomarker
Why CGRP is a promising but tricky blood marker for diagnosing and tracking migraine.
New studies explained, treatment guides and updates as they happen. Over 290 articles so far, all free to read.

Why CGRP is a promising but tricky blood marker for diagnosing and tracking migraine.

Acid reflux drugs, especially PPIs, were linked to higher migraine risk in one study.

HeadaTerm 2 is an FDA-cleared device similar to Cefaly at a fraction of the price.

An MRI study found brain differences in migraine that may help future diagnosis.

Using too little acute or preventive treatment can push migraine toward chronic.

How sleep problems, central sensitization and disability are linked in migraine.

How long to try a CGRP antibody before deciding whether it works for you.

How cluster headache and other TACs arise, from the trigeminal reflex to the hypothalamus.

Our 2024 April Fools' post. Chiropractors are not world leaders in migraine care.

Cluster Headache Treatment: Acute and Preventive

Why pain reprocessing therapy is not a suitable treatment for migraine.

What we know about autonomic nervous system dysfunction in migraine and dysautonomia.

The Truth About "Safety-Coated" NSAIDs for Migraine

The AHS now says CGRP-targeting treatments can be a first-line option for prevention.

How to Avoid Migraine Attacks During the Month of Ramadan

How Much Is Too Much Excedrin Migraine? (MWS Day 2)

Key takeaways from Peter Goadsby on CGRP and the biochemistry of migraine.

Key takeaways on the best exercise options for people with migraine.
Comparing products? See the buyer's guides.